XML 27 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net income (loss) $ 126,800 $ 187,774 $ (260,726)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation 714,345 498,134 453,935
Stock-based compensation 155,567 132,443 117,990
Excess tax benefits from stock-based compensation (2,773) (30) (19,582)
Amortization of intangible assets 122,862 27,446 27,756
Amortization of debt issuance costs and debt discounts 19,137 16,050 18,667
Provision for allowance for doubtful accounts 8,260 5,037 7,093
Gain on asset sales (32,816) 0 0
Gain on sale of discontinued operations (2,351) 0 0
Impairment charges 7,698 0 0
Loss on debt extinguishment 12,276 289 156,990
Other items 20,609 16,490 19,912
Changes in operating assets and liabilities:      
Accounts receivable (100,230) (44,583) (101,966)
Income taxes, net 29,020 (109,579) 226,774
Other assets (72,831) (70,371) (6,496)
Accounts payable and accrued expenses 61,565 109,125 10,681
Other liabilities (50,558) 126,568 38,392
Net cash provided by operating activities 1,016,580 894,793 689,420
Cash flows from investing activities:      
Purchases of investments (42,325) (359,031) (545,997)
Sales and maturities of investments 53,164 873,139 785,548
Business acquisitions, net of cash acquired (1,766,907) (245,553) 0
Purchases of real estate (28,118) (38,282) (16,791)
Purchases of other property, plant and equipment (1,113,365) (868,120) (660,203)
Proceeds from sale of assets, net of cash transferred 851,582 0 0
Increase in restricted cash (21,901) (512,319) (968)
Release of restricted cash 475,715 15,239 2,572
Net cash used in investing activities (1,592,155) (1,134,927) (435,839)
Cash flows from financing activities:      
Purchases of treasury stock 0 0 (297,958)
Proceeds from employee equity awards 34,179 30,040 29,320
Excess tax benefits from stock-based compensation 2,773 30 19,582
Payment of dividends and special distribution (499,463) (521,461) (83,266)
Purchase of non-controlling interests 0 0 (226,276)
Proceeds from public offering of common stock, net of issuance costs 0 829,496 0
Proceeds from senior notes 0 1,100,000 1,250,000
Proceeds from loans payable 1,168,304 1,197,108 508,826
Repayment of senior notes 0 0 (750,000)
Repayment of convertible debt (51) 0 (29,513)
Repayment of capital lease and other financing obligations (114,385) (28,663) (18,030)
Repayment of mortgage and loans payable (1,462,888) (715,270) (153,473)
Debt extinguishment costs (11,380) 0 (116,517)
Debt issuance costs (11,381) (18,098) (25,294)
Net cash provided by (used in) financing activities (894,292) 1,873,182 107,401
Effect of foreign currency exchange rates on cash and cash equivalents (10,495) (15,127) (11,959)
Net increase (decrease) in cash and cash equivalents (1,480,362) 1,617,921 349,023
Cash and cash equivalents at beginning of period 2,228,838 610,917 261,894
Cash and cash equivalents at end of period 748,476 2,228,838 610,917
Supplemental cash flow information      
Cash paid for taxes 39,320 132,302 117,197
Cash paid for interest $ 350,083 $ 237,410 $ 262,018